Literature DB >> 20826582

Reduced energy expenditure and impaired feeding-related signals but not high energy intake reinforces hypothalamic obesity in adults with childhood onset craniopharyngioma.

Helene Holmer1, Gabriella Pozarek, Elisabet Wirfält, Vera Popovic, Bertil Ekman, Jonas Björk, Eva-Marie Erfurth.   

Abstract

CONTEXT: Obesity is a frequent manifestation of hypothalamic damage from a craniopharyngioma (CP). It is not yet clarified whether the obesity is due to alterations in energy expenditure, i.e. basal metabolic rate (BMR) and physical activity, or to increased energy intake (EI).
OBJECTIVE: The aim was to investigate whether energy expenditure and EI differed between childhood onset CP patients and matched population controls and whether these measures were related to hypothalamic damage, as tumor growth into the third ventricle (TGTV). DESIGN AND METHODS: Forty-two CP patients (20 women) aged 28 yr (range, 17-57 yr) operated between 1958 and 2000 in the South Medical Region of Sweden (population, 2.5 million) were studied. Body composition, satiety hormones, BMR (indirect calorimetry), physical activity, EI, and attitudes toward eating were assessed. Comparisons were made with matched controls and between patients with (n=25) and without (n=17) TGTV.
RESULTS: After adjustment, patients had lower BMR compared to controls (-90 kcal/24 h; P=0.02) and also had lower EI (1778 vs. 2094 kcal/24 h; P=0.008), and the EI/BMR ratio was significantly lower in TGTV patients. Similar dietary macronutrient composition was found, and only significantly higher scales in restricting food intake were recorded in patients. Ghrelin levels were significantly lower in patients, whereas serum insulin and leptin levels were higher (P<0.001), and both ghrelin and insulin correlated significantly to tumor growth. Lower levels of physical activity (P<0.01) were recorded in patients.
CONCLUSIONS: The major mechanisms that reinforced obesity were hypothalamic damage causing disrupted or impaired sensitivity to feeding-related signals for leptin, insulin, and ghrelin, and reductions in both BMR and physical activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20826582     DOI: 10.1210/jc.2010-0993

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  29 in total

1.  Hypothalamic obesity in patients with craniopharyngioma: treatment approaches and the emerging role of gastric bypass surgery.

Authors:  Gabrielle Page-Wilson; Sharon L Wardlaw; Alexander G Khandji; Judith Korner
Journal:  Pituitary       Date:  2012-03       Impact factor: 4.107

Review 2.  Management of craniopharyngiomas.

Authors:  N Karavitaki
Journal:  J Endocrinol Invest       Date:  2014-03       Impact factor: 4.256

3.  Psychometric Analysis of the Three-Factor Eating Questionnaire-R18V2 in Adolescent and Young Adult-Aged Central Nervous System Tumor Survivors.

Authors:  Maria C Swartz; Karen M Basen-Engquist; Christine Markham; Elizabeth J Lyons; Matthew Cox; Joya Chandra; Joann L Ater; Martha A Askins; Michael E Scheurer; Philip J Lupo; Rachel Hill; Jeffrey Murray; Wenyaw Chan; Paul R Swank
Journal:  J Adolesc Young Adult Oncol       Date:  2016-04-04       Impact factor: 2.223

Review 4.  Risk-adapted, long-term management in childhood-onset craniopharyngioma.

Authors:  Hermann L Müller
Journal:  Pituitary       Date:  2017-04       Impact factor: 4.107

Review 5.  Childhood craniopharyngioma.

Authors:  Hermann L Müller
Journal:  Pituitary       Date:  2013-03       Impact factor: 4.107

6.  A 52-week pilot study of the effects of exenatide on body weight in patients with hypothalamic obesity.

Authors:  Jefferson P Lomenick; Maciej S Buchowski; Ashley H Shoemaker
Journal:  Obesity (Silver Spring)       Date:  2016-05-02       Impact factor: 5.002

7.  Postnatal ablation of POMC neurons induces an obese phenotype characterized by decreased food intake and enhanced anxiety-like behavior.

Authors:  Yona Greenman; Yael Kuperman; Yonat Drori; Sylvia L Asa; Inbal Navon; Oren Forkosh; Shosh Gil; Naftali Stern; Alon Chen
Journal:  Mol Endocrinol       Date:  2013-05-15

Review 8.  Mortality and morbidity in adult craniopharyngioma.

Authors:  Eva Marie Erfurth; Helene Holmer; Sigridur Bara Fjalldal
Journal:  Pituitary       Date:  2013-03       Impact factor: 4.107

Review 9.  Investigating metabolic regulation using targeted neuromodulation.

Authors:  Kavya Devarakonda; Sarah Stanley
Journal:  Ann N Y Acad Sci       Date:  2017-11-06       Impact factor: 5.691

10.  Long term sequelae of pediatric craniopharyngioma - literature review and 20 years of experience.

Authors:  Michal Cohen; Sharon Guger; Jill Hamilton
Journal:  Front Endocrinol (Lausanne)       Date:  2011-11-28       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.